Mikosha A S, Berezovskaia N N
Probl Endokrinol (Mosk). 1983 Sep-Oct;29(5):62-5.
A study was made of the action of the adrenocorticolytic drug chloditane (o.p'-DDD) on the content of cytochrome P-450 adrenodoxine and free radicals in the dog adrenal cortex. After a single feeding of 50 mg/kg bw o.p'-DDD EPR signals with xi-factors 2.25, 1.94 and 2.00 reduced 30-40%. Three-fold feeding of the drug in a dose of 100 mg/kg bw produced a further demonstrable decrease of signals. These changes attest to a possible inhibition of the hydroxylase complex in the adrenal cortex induced by o.p'-DDD.
研究了肾上腺皮质溶解药物氯地孕酮(邻对二氯二苯二氯乙烷,o.p'-DDD)对犬肾上腺皮质中细胞色素P-450、肾上腺皮质激素和自由基含量的作用。单次喂食50mg/kg体重的o.p'-DDD后,g因子为2.25、1.94和2.00的电子顺磁共振(EPR)信号降低了30-40%。以100mg/kg体重的剂量三次喂食该药物后,信号进一步明显降低。这些变化证明o.p'-DDD可能抑制肾上腺皮质中的羟化酶复合物。